These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 5416637)

  • 1. An incompatibility in the reaction of the second component of human complement with the fourth component of guinea-pig complement.
    Tamura N
    Immunology; 1970 Feb; 18(2):203-12. PubMed ID: 5416637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. 3. The hemolytic efficiency of human and guinea pig C2 and C4.
    Opferkuch W; Rapp HJ; Colten HR; Borsos T
    J Immunol; 1971 Apr; 106(4):927-31. PubMed ID: 4995006
    [No Abstract]   [Full Text] [Related]  

  • 4. Lytic activity of C5-9 complexes for erythrocytes from the species other than sheep: C9 rather than C8-dependent variation in lytic activity.
    Yamamoto KI
    J Immunol; 1977 Oct; 119(4):1482-5. PubMed ID: 894048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent and consecutive action of the complement components C5, C6 and C7 in immune hemolysis. I. Preparation of EAC1-5 with purified guinea pig C3 and C5.
    Bitter-Suermann D; Hadding U; Melchert F; Wellensiek HJ
    Immunochemistry; 1970 Dec; 7(12):955-65. PubMed ID: 5503627
    [No Abstract]   [Full Text] [Related]  

  • 6. The first component of guinea pig complement: hemolytic assays with EA, EAC4 and with rat and guinea pig late acting components.
    Opferkuch W; Rapp HJ; Colten HR; Borsos T
    Immunochemistry; 1971 Jun; 8(6):517-23. PubMed ID: 4997463
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. I. Antibody and serum requirements.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1671-7. PubMed ID: 4750864
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of Cu-chlorophyllin on the active site formation of each component of guinea-pig complement.
    Okada H; Nishioka K; Sindo T
    Immunology; 1969 Apr; 16(4):473-80. PubMed ID: 5770389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH; Abramovitz AS; Mayer MM
    J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of the reaction of C9 with EAC1-8: reaction of C9 with EAC1-8.
    Kitamura H; Inai S
    J Immunol; 1974 Dec; 113(6):1992-2003. PubMed ID: 4214868
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement dependent hemolysis of sheep erythrocytes coupled with non-antibody human IgG.
    Inai S; Tsuyuguchi I
    Biken J; 1968 Dec; 11(4):261-7. PubMed ID: 4181155
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody-complement complexes.
    Willoughby WF; Mayer MM
    Science; 1965 Nov; 150(3698):907-8. PubMed ID: 4953701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement.
    Gaither TA; Alling DW; Frank MM
    J Immunol; 1974 Aug; 113(2):574-83. PubMed ID: 4210883
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement: optimal reaction conditions for guinea pig C4.
    Linscott WD
    J Immunol; 1973 Jul; 111(1):189-99. PubMed ID: 4197333
    [No Abstract]   [Full Text] [Related]  

  • 15. A specific method for purification of the second component of guinea pig complement and a chemical evaluation of the one-hit theory.
    Mayer MM; Miller JA; Shin HS
    J Immunol; 1970 Aug; 105(2):327-41. PubMed ID: 5433696
    [No Abstract]   [Full Text] [Related]  

  • 16. The purification and reactivity of the first component of complement from guinea pig, human and canine sera.
    Tamura N; Nelson RA
    J Immunol; 1968 Dec; 101(6):1333-45. PubMed ID: 4972623
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune lytic transformation: a state of irreversible damage generated as a result of the reaction of the eighth component in the guinea pig complement system.
    Stolfi RL
    J Immunol; 1968 Jan; 100(1):46-54. PubMed ID: 4169697
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigenic relationship between the fourth component of human and guinea pig complement.
    Ohanian SH; Borsos T
    J Immunol; 1975 Jan; 114(1 Pt 1):161-4. PubMed ID: 46239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An explanation for the inefficiency of guinea pig complement in the cytolysis of sheep erythrocytes or rat mast cells sensitized with rabbit antiserum: a double block.
    Kempf RA; Gigli I; Austen KF
    Transplant Proc; 1969 Mar; 1(1):626-8. PubMed ID: 4109231
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of guinea pig complement component C9: reaction kinetics and evidence that lysis of EAC1-8 results from a single membrane lesion caused by one molecule of C9.
    Rommel FA; Mayer MM
    J Immunol; 1973 Mar; 110(3):637-47. PubMed ID: 4688916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.